These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36983191)

  • 1. Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
    Gelato F; Mastorino L; Stepkina E; Cavaliere G; Ribero S; Quaglino P; Ortoncelli M
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and biomarker differences of severe intrinsic and extrinsic atopic dermatitis.
    Liu Z; Shi Z; Deng Y
    Cutan Ocul Toxicol; 2024 Mar; 43(1):97-103. PubMed ID: 38258428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive skin is highly frequent in extrinsic atopic dermatitis and correlates with disease severity markers but not necessarily with skin barrier impairment.
    Yatagai T; Shimauchi T; Yamaguchi H; Sakabe JI; Aoshima M; Ikeya S; Tatsuno K; Fujiyama T; Ito T; Ojima T; Tokura Y
    J Dermatol Sci; 2018 Jan; 89(1):33-39. PubMed ID: 29122406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-life experience in the effectiveness, impact on quality of life and safety of dupilumab treatment in patients with moderate to severe atopic dermatitis in the Czech Republic.
    Tánczosová M; Kojanová M; Arenbergerová M; Arenberger P; Doležal T; Štrosová D; Fialová J; Gkalpakiotis S
    Cent Eur J Public Health; 2022 Mar; 30(1):46-50. PubMed ID: 35421298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotyping of epidermal dendritic cells allows the differentiation between extrinsic and intrinsic forms of atopic dermatitis.
    Oppel T; Schuller E; Günther S; Moderer M; Haberstok J; Bieber T; Wollenberg A
    Br J Dermatol; 2000 Dec; 143(6):1193-8. PubMed ID: 11122020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Pruritus in Atopic Patients Treated with Dupilumab: Real Life Response and Related Parameters in 354 Patients.
    Mastorino L; Rosset F; Gelato F; Ortoncelli M; Cavaliere G; Quaglino P; Ribero S
    Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological Sex and IgE Sensitization Influence Severity of Depression and Cortisol Levels in Atopic Dermatitis.
    Vinnik T; Kreinin A; Abildinova G; Batpenova G; Kirby M; Pinhasov A
    Dermatology; 2020; 236(4):336-344. PubMed ID: 31914445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of the extrinsic and intrinsic types of adult-onset atopic dermatitis.
    Kulthanan K; Boochangkool K; Tuchinda P; Chularojanamontri L
    Asia Pac Allergy; 2011 Jul; 1(2):80-6. PubMed ID: 22053301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of CC chemokine ligand 18 in extrinsic atopic dermatitis patients.
    Park CO; Lee HJ; Lee JH; Wu WH; Chang NS; Hua L; Lee MG; Lee KH
    Exp Dermatol; 2008 Jan; 17(1):24-9. PubMed ID: 17979978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials.
    Griffiths C; de Bruin-Weller M; Deleuran M; Fargnoli MC; Staumont-Sallé D; Hong CH; Sánchez-Carazo J; Foley P; Seo SJ; Msihid J; Chen Z; Cyr SL; Rossi AB
    Dermatol Ther (Heidelb); 2021 Aug; 11(4):1357-1372. PubMed ID: 34142350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin A deficiency exacerbates extrinsic atopic dermatitis development by potentiating type 2 helper T cell-type inflammation and mast cell activation.
    Yang H; Chen JS; Zou WJ; Tan Q; Xiao YZ; Luo XY; Gao P; Fu Z; Wang H
    Clin Exp Allergy; 2020 Aug; 50(8):942-953. PubMed ID: 32559330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evaluation of dupilumab treatment response in atopic dermatitis patients.
    Askin O; Yucesoy SN; Serdaroglu S
    North Clin Istanb; 2021; 8(2):145-149. PubMed ID: 33851078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis.
    Yosipovitch G; de Bruin-Weller M; Armstrong A; Wu JJ; Herranz P; Thaçi D; Delevry D; Bagousse GB; Zhang R; Shumel B; Rossi AB; Chao J
    Dermatol Ther (Heidelb); 2021 Dec; 11(6):2147-2157. PubMed ID: 34714527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of adult patients with atopic dermatitis treated with dupilumab: A single-center real-life experience.
    Su Küçük Ö; Güneş B; Taşlidere N; Işik BG; Akaslan TÇ; Özgen FP; Bahali AG
    J Cosmet Dermatol; 2022 Oct; 21(10):4781-4787. PubMed ID: 35038377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dupilumab for atopic dermatitis: a real-world Portuguese multicenter retrospective study.
    Torres T; Paiva-Lopes MJ; Gonçalo M; Claro C; Oliveira M; Gomes J; Vieira AP; Amoedo P; Alpalhão M; Nogueira M; Santiago F; Henrique M; Amaro C; Esteves T; Alves J; Cerejeira D; Mendes-Bastos P; Pestana M; Ramos L; Rocha J; Carvalho R; Teixeira L; Selores M; Mota A; Filipe P;
    J Dermatolog Treat; 2022 Aug; 33(5):2554-2559. PubMed ID: 35083945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.
    Beck LA; Deleuran M; Bissonnette R; de Bruin-Weller M; Galus R; Nakahara T; Seo SJ; Khokhar FA; Vakil J; Xiao J; Marco AR; Levit NA; O'Malley JT; Shabbir A
    Am J Clin Dermatol; 2022 May; 23(3):393-408. PubMed ID: 35503163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Dupilumab in Chinese Patients With Atopic Dermatitis: A Real-World Study.
    Zhou B; Peng C; Li L; Liu R; Zhu L; Chen X; Li J
    Front Med (Lausanne); 2022; 9():838030. PubMed ID: 35402441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Dupilumab in 543 Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Retrospective Study.
    Nettis E; Ferrucci SM; Ortoncelli M; Pellacani G; Foti C; Di Leo E; Patruno C; Rongioletti F; Argenziano G; Macchia L; Tavecchio S; Napolitano M; Ribero S; Bonzano L; Romita P; Di Bona D; Nisticò SP; Piras V; Calabrese G; Detoraki C; Carbonara M; Fabbrocini G
    J Investig Allergol Clin Immunol; 2022 Apr; 32(2):124-132. PubMed ID: 32856595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total serum IgE as a parameter to differentiate between intrinsic and extrinsic atopic dermatitis in children.
    Ott H; Stanzel S; Ocklenburg C; Merk HF; Baron JM; Lehmann S
    Acta Derm Venereol; 2009; 89(3):257-61. PubMed ID: 19479121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.
    Suárez-Fariñas M; Dhingra N; Gittler J; Shemer A; Cardinale I; de Guzman Strong C; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2013 Aug; 132(2):361-70. PubMed ID: 23777851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.